Condition : Rheumatoid Arthritis Intervention : Drug: LY2127399 Sponsor : Eli Lilly and Company Recruiting - verified July 2011

Condition : Rheumatoid Arthritis Intervention : Drug: LY2127399 Sponsor : Eli Lilly and Company Recruiting - verified August 2011

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Recruiting - verified July 2011

Condition : Arthritis, Rheumatoid Intervention : Sponsor : Biogen Idec Active, not recruiting - verified August 2011

Condition : Arthritis, Rheumatoid Interventions

Condition : Spondylitis, Ankylosing Interventions

Condition : Arthritis, Rheumatoid Interventions

Condition : Spondylitis, Ankylosing Interventions

Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks Sponsor : Eli Lilly and Company Recruiting - verified July 2011

Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks Sponsor : Eli Lilly and Company Recruiting - verified July 2011